KRAS inhibitor programme (Redx Pharma)

N/A

Report date: 2025/06/11 10:17:22
NME

Base Information

Drug NameKRAS inhibitor programme (Redx Pharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRedx Pharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesRedx Pharma Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A